Showing results (241-250 of 790) with videos related to
Sort By:
Pageof 79
Scientific Reports|June 9, 2016
Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathwayAe Lee Jeong, Sora Han, Sunyi Lee, et al.The Journal of Clinical Investigation|July 14, 2007
Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancerIsabel Chu, Angel Arnaout, Sophie Loiseau, et al.Plos Genetics|April 6, 2012
LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patientsMyLinh T Duong, Said Akli, Caimiao Wei, et al.Cancer Cell|February 21, 2012
Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cellsTaru Muranen, Laura M Selfors, Devin T Worster, et al.Oncogene|March 26, 2025
Rictor orchestrates β-catenin/FOXO balance by maintaining redox homeostasis during development of ovarian cancerXuejiao Zhao, Huiling Lai, Guannan Li, et al.Cancer Research|January 20, 2007
Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cellsYoko Tabe, Linhua Jin, Yuko Tsutsumi-Ishii, et al.Breast Cancer Research : BCR|October 30, 2012
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancerFunda Meric-Bernstam, Huiqin Chen, Argun Akcakanat, et al.Nature Communications|September 24, 2017
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancerShreya Mitra, Jeffrey E Montgomery, Matthew J Kolar, et al.Cancer Letters|June 3, 2018
Autotaxin exacerbates tumor progression by enhancing MEK1 and overriding the function of miR-489-3pSudeepti S Kuppa, Wei Jia, Shuying Liu, et al.Plos One|September 21, 2011
Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancerSofie Claerhout, Jae Yun Lim, Woonyoung Choi, et al.Pageof 79